BAXTER POTASSIUM CHLORIDE 10 mmol and 0.29% SODIUM CHLORIDE 100 mL intravenous infusion bag Australija - engleski - Department of Health (Therapeutic Goods Administration)

baxter potassium chloride 10 mmol and 0.29% sodium chloride 100 ml intravenous infusion bag

baxter healthcare pty ltd - sodium chloride, quantity: 2.92 g/l; potassium chloride, quantity: 7.46 g/l - injection, intravenous infusion - excipient ingredients: water for injections - the baxter potassium chloride and sodium chloride intravenous infusion is indicated as a source of water and to restore electrolyte balance as required by the patient's clinical condition, such as hypokalaemia.

Rennie Direct 680 mg/80 mg oral powder Irska - engleski - HPRA (Health Products Regulatory Authority)

rennie direct 680 mg/80 mg oral powder

bayer limited - magnesium carbonate heavy; calcium carbonate - oral powder - 680 mg/80 milligram(s) - antacids, other combinations

Sodium Chloride 0.3 % w/v and Glucose 3.3% w/v Solution for Infusion BP Irska - engleski - HPRA (Health Products Regulatory Authority)

sodium chloride 0.3 % w/v and glucose 3.3% w/v solution for infusion bp

baxter holding b.v. - sodium chloride; glucose - solution for infusion - 0.3/ 3.3 percent weight/volume - salt solutions; sodium chloride

Sodium Chloride 0.45 % w/v and Glucose 2.5% w/v Solution for Infusion BP Irska - engleski - HPRA (Health Products Regulatory Authority)

sodium chloride 0.45 % w/v and glucose 2.5% w/v solution for infusion bp

baxter holding b.v. - sodium chloride; glucose - solution for infusion - 0.45/2.5 percent weight/volume - salt solutions; sodium chloride

Sodium Chloride 0.45% w/v Solution for Infusion Irska - engleski - HPRA (Health Products Regulatory Authority)

sodium chloride 0.45% w/v solution for infusion

baxter holding b.v. - sodium chloride - solution for infusion - 0.45 percent weight/volume - electrolyte solutions; sodium chloride

Sodium Chloride 0.9 % w/v and Glucose 5% w/v Solution for Infusion BP (Viaflo container) Irska - engleski - HPRA (Health Products Regulatory Authority)

sodium chloride 0.9 % w/v and glucose 5% w/v solution for infusion bp (viaflo container)

baxter holding b.v. - sodium chloride; glucose - solution for infusion - 0.9/5 percent weight/volume - salt solutions; sodium chloride

Sodium Chloride Intravenous Infusion BP 0.9% w/v (viaflex container) Irska - engleski - HPRA (Health Products Regulatory Authority)

sodium chloride intravenous infusion bp 0.9% w/v (viaflex container)

baxter holding b.v. - sodium chloride - solution for infusion - 0.9 percent weight/volume - electrolyte solutions; sodium chloride

BIOLOGICAL THERAPIES DISODIUM EDETATE 3g + SODIUM ASCORBATE 5g 50mL injection vial Australija - engleski - Department of Health (Therapeutic Goods Administration)

biological therapies disodium edetate 3g + sodium ascorbate 5g 50ml injection vial

orthomolecular medisearch laboratories pty ltd trading as biological therapies - sodium ascorbate, quantity: 100 mg/ml; disodium edetate, quantity: 60 mg/ml - injection, concentrated - excipient ingredients: water for injections; sodium hydroxide - 1. disodium edetate is particularly effective in treating lead accumulation and lead poisoning. this is especially so where there is a concomitant hypercalcaemic problem (refer "indications (2)"). however it must be noted that disodium edetate is equally effective with calcium disodium edetate in removing heavy metals, even in the absence of hypercalcaemia. for patients with elevated serum calcium or hypermobility of their body pools of calcium where there may be transiently or prolonged raised serum calcium (see "indications (2)"), the edta of choice for removing heavy metals may be disodium edetate. there are no recognised safe limits for lead intoxication. lead poisoning may occur by ingestion or inhalation of lead dust or fumes. poisoning is manifested by a metallic taste, anorexia, irritability, apathy, abdominal colic, vomiting, diarrhoea, constipation, headache, leg cramps, black stools, oliguria, stupor, convulsions, palsies and coma. chronic lead poisoning causes variable involvement of the central n

BIOLOGICAL THERAPIES DISODIUM EDETATE SOLUTION 3g/100mL injection vial Australija - engleski - Department of Health (Therapeutic Goods Administration)

biological therapies disodium edetate solution 3g/100ml injection vial

orthomolecular medisearch laboratories pty ltd trading as biological therapies - disodium edetate, quantity: 30 mg/ml - injection, concentrated - excipient ingredients: water for injections - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code) 1. disodium edetate is particularly effective in treating lead accumulation and lead poisoning. this is especially so where there is a concomitant hypercalcaemic problem (refer "indications (2)"). however it must be noted that disodium edetate is equally effective with calcium disodium edetate in removing heavy metals, even in the absence of hypercalcaemia. for patients with elevated serum calcium or hypermobility of their body pools of calcium where there may be transiently or prolonged raised serum calcium (see "indications (2)"), the edta of choice for removing heavy metals may be disodium edetate. there are no recognised safe limits for lead intoxication. lead poisoning may occur by ingestion or inhalation of lead dust or fumes. poisoning is manifested by a metallic taste, anorexia, irritability, apathy, abdominal colic, vomiting, diarrhoea, cons

BAXTER HEPARIN SODIUM 2000IU 1000mL injection AHB0944A Australija - engleski - Department of Health (Therapeutic Goods Administration)

baxter heparin sodium 2000iu 1000ml injection ahb0944a

baxter healthcare pty ltd - heparin sodium, quantity: 2000 iu/l - injection, solution - excipient ingredients: water for injections; sodium chloride; citric acid monohydrate; dibasic sodium phosphate dodecahydrate - indications as at 11 july 2003: heparin sodium in 0.9% sodium chloride intravenous infusion is indicated as an anticoagulant in extracorporeal circulation, dialysis procedures, and as an aid in the maintenance of catheter patency.